{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:34:48Z","timestamp":1777480488349,"version":"3.51.4"},"reference-count":19,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2022,2,14]]},"abstract":"<jats:p>BACKGROUND: Patients undergoing screening for early detection of cancer have serial biomarker measurements that are not traditionally being incorporated into decision making when evaluating biomarkers. OBJECTIVE: We discuss statistical learning algorithms that have the ability to learn from patient history to make personalized decision rules to improve the early detection of cancer. These artificial intelligence algorithms are able to learn in real time from data collected on the patient to identify changes in the patient that could signal asymptomatic cancer. METHODS: We discuss the parametric empirical Bayes (PEB) algorithm for a single biomarker and a Bayesian screening algorithm for multiple biomarkers. RESULTS: We provide tools to implement these algorithms and discuss their clinical utility for the early detection of hepatocellular carcinoma (HCC). The PEB algorithm is a robust, easily implemented algorithm for defining patient specific thresholds that can improve the patient-level sensitivity of a biomarker in many settings, including HCC. The fully Bayesian algorithm, while more complex, can accommodate multiple biomarkers and further improve the clinical utility of the algorithms. CONCLUSIONS: These algorithms could be used in many clinical settings and we aim to guide the reader on how these algorithms may improve the detection performance of their biomarkers.<\/jats:p>","DOI":"10.3233\/cbm-210307","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T13:20:22Z","timestamp":1645536022000},"page":"199-210","source":"Crossref","is-referenced-by-count":5,"title":["Personalized statistical learning algorithms to improve the early detection of cancer using longitudinal biomarkers"],"prefix":"10.1177","volume":"33","author":[{"given":"Nabihah","family":"Tayob","sequence":"first","affiliation":[{"name":"Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USA"},{"name":"Department of Medicine, Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziding","family":"Feng","sequence":"additional","affiliation":[{"name":"Biostatistics Program, Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"1","key":"10.3233\/CBM-210307_ref1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biostatistics\/4.1.27","article-title":"A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker","volume":"4","author":"McIntosh","year":"2003","journal-title":"Biostatistics"},{"issue":"454","key":"10.3233\/CBM-210307_ref2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1198\/016214501753168145","article-title":"Screening based on the risk of cancer calculation from Bayesian hierarchical changepoint and mixture models of longitudinal markers","volume":"96","author":"Skates","year":"2001","journal-title":"J Am Stat Assoc"},{"issue":"31","key":"10.3233\/CBM-210307_ref3","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1200\/JCO.2005.01.6642","article-title":"Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer","volume":"23","author":"Menon","year":"2005","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.3233\/CBM-210307_ref4","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1097\/IGC.0b013e318256488a","article-title":"Ovarian cancer screening: Development of the risk of ovarian cancer algorithm (ROCA) and ROCA screening trials","volume":"22","author":"Skates","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.3233\/CBM-210307_ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/biom.12717","article-title":"A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers","author":"Tayob","year":"2017","journal-title":"Biometrics"},{"issue":"14","key":"10.3233\/CBM-210307_ref6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.3233\/CBM-210307_ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.01.233"},{"issue":"3","key":"10.3233\/CBM-210307_ref8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2010.11.050","article-title":"Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis {C}","volume":"140","author":"Lok","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.3233\/CBM-210307_ref9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.3233\/CBM-210307_ref10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1158\/1055-9965.EPI-11-1005","article-title":"Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"21","author":"Singal","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.3233\/CBM-210307_ref11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.3233\/CBM-210307_ref12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1158\/1055-9965.EPI-13-0870","article-title":"The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.3233\/CBM-210307_ref13","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1053\/j.gastro.2014.01.045","article-title":"A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis","volume":"146","author":"El-Serag","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.3233\/CBM-210307_ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0458-6","article-title":"Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the veteran\u2019s affairs health care system","volume":"18","author":"Tayob","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"10.3233\/CBM-210307_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/"},{"key":"10.3233\/CBM-210307_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.07.065"},{"issue":"3","key":"10.3233\/CBM-210307_ref17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cgh.2015.07.049","article-title":"Improved detection of hepatocellular carcinoma by using a longitudinal alpha-fetoprotein screening algorithm","volume":"14","author":"Tayob","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.3233\/CBM-210307_ref18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"U.S. Preventive Services Task Force. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.3233\/CBM-210307_ref19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1148\/radiol.2019181113","article-title":"Digital mammography in breast cancer: additive value of radiomics of breast parenchyma","volume":"291","author":"Li","year":"2019","journal-title":"Radiology"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-210307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:28Z","timestamp":1777385308000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-210307"}},"subtitle":[],"editor":[{"given":"Karin D.","family":"Rodland","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":19,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/cbm-210307","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,14]]}}}